Your browser doesn't support javascript.
loading
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Magavern, Emma F; Kaski, Juan Carlos; Turner, Richard M; Drexel, Heinz; Janmohamed, Azara; Scourfield, Andrew; Burrage, Daniel; Floyd, Christopher N; Adeyeye, Elizabeth; Tamargo, Juan; Lewis, Basil S; Kjeldsen, Keld Per; Niessner, Alexander; Wassmann, Sven; Sulzgruber, Patrick; Borry, Pascal; Agewall, Stefan; Semb, Anne Grete; Savarese, Gianluigi; Pirmohamed, Munir; Caulfield, Mark J.
Afiliação
  • Magavern EF; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Kaski JC; Department of Clinical Pharmacology, Cardiovascular Medicine, Barts Health NHS Trust, London, UK.
  • Turner RM; Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
  • Drexel H; The Wolfson Centre for Personalised Medicine, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, UK.
  • Janmohamed A; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Scourfield A; Vorarlberg Institute for Vascular Investigation & Treatment (VIVIT), Feldkirch,Austria.
  • Burrage D; Private University of the Principality of Liechtenstein, Triesen, Liechtenstein.
  • Floyd CN; Drexel University College of Medicine, Philadelphia, PA, USA.
  • Adeyeye E; Department of Clinical Pharmacology, St George's University of London, London, UK.
  • Tamargo J; Department of Clinical Pharmacology, University College London Hospital Foundation Trust, London, UK.
  • Lewis BS; Whittington Health NHS Trust, London, UK.
  • Kjeldsen KP; King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.
  • Niessner A; Department of Clinical Pharmacology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Wassmann S; Department of Clinical Pharmacology, Cardiovascular Medicine, Barts Health NHS Trust, London, UK.
  • Sulzgruber P; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
  • Borry P; Cardiovascular Clinical Research Institute, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Agewall S; Department of Cardiology, Copenhagen University Hospital (Amager-Hvidovre), Copenhagen, Denmark.
  • Semb AG; Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, Denmark.
  • Savarese G; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
  • Pirmohamed M; Cardiology Pasing, Munich,Germany.
  • Caulfield MJ; University of the Saarland, Homburg/Saar, Germany.
Eur Heart J Cardiovasc Pharmacother ; 8(1): 100-103, 2022 01 05.
Article em En | MEDLINE | ID: mdl-34463331
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiologia / Sistema Cardiovascular Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Eur Heart J Cardiovasc Pharmacother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiologia / Sistema Cardiovascular Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Eur Heart J Cardiovasc Pharmacother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido